AT2R Antagonist Ring Derivatives for Neuropathic Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drugs for neuropathic pain, such as antiepileptic drugs and antidepressants, have limited therapeutic effects and significant side effects, necessitating the development of new angiotensin II type 2 receptor (AT2R) antagonists with improved efficacy and reduced adverse reactions.
Innovation Solution
Development of a new class of aromatic and heteroaromatic ring derivatives as AT2R antagonists, represented by general formulas (I), (II), and (III), which include specific structural variations and functional groups to enhance therapeutic efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antiepileptic drugs and antidepressants are used for neuropathic pain treatment, then therapeutic coverage is provided, but side effects increase and therapeutic efficacy is limited
Solution Approach 1:
The patent changes the pharmacological target parameter from non-specific neurotransmitter modulation to specific AT2R receptor antagonism. The compounds of formula (I) are designed to selectively block AT2R, transforming the treatment approach from broad-spectrum to targeted therapy, thereby improving efficacy while reducing off-target side effects
Solution Approach 2:
The patent segments the angiotensin II receptor system into distinct subtypes (AT1R and AT2R) and selectively targets AT2R with compounds of formula (I). This segmentation allows for specific therapeutic action on pain pathways mediated by AT2R without affecting other receptor systems, reducing cross-reactivity and associated side effects
2Reliability
If current neuropathic pain drugs are used, then some therapeutic effect is achieved, but cognitive changes and dependence occur
Solution Approach 1:
The patent introduces AT2R as a specific intermediary target for neuropathic pain treatment. Compounds of formula (I) act as intermediaries that selectively bind to and block AT2R, providing therapeutic effect without the cognitive and dependence issues associated with traditional drugs that act on broader neurotransmitter systems
3Reliability
If AT2R antagonists are developed, then neuropathic pain relief is improved, but new compound structures require extensive research and development
Solution Approach 1:
The patent establishes a universal structural framework (formula (I)) that can accommodate multiple variations of R1, R2, R3, and ring A substituents. This multi-functional framework allows systematic exploration of structure-activity relationships while maintaining the core AT2R antagonistic mechanism, facilitating efficient drug development
Solution Approach 2:
The patent systematically varies structural parameters (R1, R2, R3, ring A substituents) within the formula (I) framework to optimize AT2R binding affinity and selectivity. By changing these parameters methodically, the patent enables efficient structure-activity relationship studies without requiring complete redesign of the molecular scaffold
Data Source
AI summary
The present invention relates to aromatic ring or heteroaromatic ring derivatives, a preparation method therefor and applications thereof in medicine. Specifically, the present invention relates to aromatic ring or heteroaromatic ring derivatives represented by general formula (I), a preparation method therefor and pharmaceutically acceptable salts thereof, as well as a use thereof as therapeutic agents, especially uses as angiotensin II type 2 receptor (AT2R) antagonists, wherein the definition of each substituent in the general formula (I) is the same as the definition thereof in the description.